Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@GeneToGreen Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1225349838990139396.png) @GeneToGreen Jane

Jane posts on X about $nktr, eli lilly, betting, eli the most. They currently have XX followers and X posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1225349838990139396/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1225349838990139396/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX +156%

### Mentions: X [#](/creator/twitter::1225349838990139396/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1225349838990139396/c:line/m:posts_active.svg)


### Followers: XX [#](/creator/twitter::1225349838990139396/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1225349838990139396/c:line/m:followers.svg)

- X Week XX +2.50%
- X Month XX +28%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1225349838990139396/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1225349838990139396/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1225349838990139396/influence)
---

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance) 

**Social topic influence**
[$nktr](/topic/$nktr), [eli lilly](/topic/eli-lilly), [betting](/topic/betting), [eli](/topic/eli), [upside](/topic/upside), [$rcus](/topic/$rcus), [signals](/topic/signals), [acquisition](/topic/acquisition)

**Top assets mentioned**
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
### Top Social Posts [#](/creator/twitter::1225349838990139396/posts)
---
Top posts by engagements in the last XX hours

"$nktr stock down October OTM call options up. Probably betting on upside potential if there is a settlement in the trial against Eli Lilly"  
[X Link](https://x.com/GeneToGreen/status/1976000955335266375) [@GeneToGreen](/creator/x/GeneToGreen) 2025-10-08T19:05Z XX followers, XXX engagements


"TIGIT comeback 26.7-month OS signal for Domvanalimab in gastric cancer and what it means for $RCUS X TIGIT inhibitors have disappointed. Roche tiragolumab and Merck vibostolimab both showed Phase X signals but failed in Phase X (SKYSCRAPER-01 KEYVIBE)"  
[X Link](https://x.com/GeneToGreen/status/1978763594935185709) [@GeneToGreen](/creator/x/GeneToGreen) 2025-10-16T10:02Z XX followers, XXX engagements


"@RNAiAnalyst BioNTech acquiring Curevac was a litigation acquisition cleanup"  
[X Link](https://x.com/GeneToGreen/status/1979263083936698682) [@GeneToGreen](/creator/x/GeneToGreen) 2025-10-17T19:07Z XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@GeneToGreen Avatar @GeneToGreen Jane

Jane posts on X about $nktr, eli lilly, betting, eli the most. They currently have XX followers and X posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX -XX%
  • X Month XXXXX +156%

Mentions: X #

Mentions Line Chart

Followers: XX #

Followers Line Chart

  • X Week XX +2.50%
  • X Month XX +28%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks finance

Social topic influence $nktr, eli lilly, betting, eli, upside, $rcus, signals, acquisition

Top assets mentioned Eli Lilly and Company (LLY)

Top Social Posts #


Top posts by engagements in the last XX hours

"$nktr stock down October OTM call options up. Probably betting on upside potential if there is a settlement in the trial against Eli Lilly"
X Link @GeneToGreen 2025-10-08T19:05Z XX followers, XXX engagements

"TIGIT comeback 26.7-month OS signal for Domvanalimab in gastric cancer and what it means for $RCUS X TIGIT inhibitors have disappointed. Roche tiragolumab and Merck vibostolimab both showed Phase X signals but failed in Phase X (SKYSCRAPER-01 KEYVIBE)"
X Link @GeneToGreen 2025-10-16T10:02Z XX followers, XXX engagements

"@RNAiAnalyst BioNTech acquiring Curevac was a litigation acquisition cleanup"
X Link @GeneToGreen 2025-10-17T19:07Z XX followers, XXX engagements

creator/x::GeneToGreen
/creator/x::GeneToGreen